Plexus (PLXS) to Release Earnings on Wednesday

Plexus (NASDAQ:PLXS) will be releasing its earnings data after the market closes on Wednesday, April 24th. Analysts expect Plexus to post earnings of $0.77 per share for the quarter. Plexus has set its Q2 2024 guidance at 0.480-0.630 EPS.Persons interested in registering for the company’s earnings conference call can do so using this link.

Plexus (NASDAQ:PLXS) last released its earnings results on Thursday, January 25th. The technology company reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.01). Plexus had a return on equity of 12.16% and a net margin of 3.08%. The business had revenue of $982.61 million for the quarter, compared to the consensus estimate of $982.57 million. During the same quarter in the previous year, the company earned $1.49 earnings per share. The firm’s revenue for the quarter was down 10.2% on a year-over-year basis. On average, analysts expect Plexus to post $4 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Plexus Stock Up 1.0 %

Shares of PLXS opened at $94.19 on Tuesday. Plexus has a 52 week low of $83.84 and a 52 week high of $114.06. The stock has a market capitalization of $2.60 billion, a price-to-earnings ratio of 20.98 and a beta of 1.02. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.62 and a current ratio of 1.52. The stock has a fifty day moving average of $94.26 and a 200-day moving average of $98.37.

Wall Street Analyst Weigh In

PLXS has been the subject of a number of research reports. Benchmark reiterated a “buy” rating and issued a $110.00 price target on shares of Plexus in a research note on Wednesday, January 17th. Needham & Company LLC dropped their price target on Plexus from $110.00 to $107.00 and set a “buy” rating for the company in a research note on Thursday, January 25th. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price target for the company. in a research note on Tuesday, January 9th. Finally, TheStreet cut Plexus from a “b” rating to a “c+” rating in a research note on Tuesday, February 13th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Plexus has an average rating of “Moderate Buy” and a consensus target price of $109.67.

Insider Activity at Plexus

In other Plexus news, CFO Patrick John Jermain sold 2,532 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $92.51, for a total transaction of $234,235.32. Following the completion of the sale, the chief financial officer now owns 54,651 shares of the company’s stock, valued at approximately $5,055,764.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Plexus news, CFO Patrick John Jermain sold 2,532 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $92.51, for a total transaction of $234,235.32. Following the completion of the sale, the chief financial officer now owns 54,651 shares of the company’s stock, valued at approximately $5,055,764.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Todd P. Kelsey sold 2,000 shares of the stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $94.00, for a total transaction of $188,000.00. Following the sale, the chief executive officer now directly owns 121,310 shares of the company’s stock, valued at approximately $11,403,140. The disclosure for this sale can be found here. Insiders have sold 32,453 shares of company stock worth $3,112,875 over the last ninety days. Insiders own 2.39% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.